NN Investment Partners Holdings’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-42,534
| Closed | -$7.81M | – | 888 |
|
|
2021
Q2 | $7.81M | Buy |
42,534
+1,986
| +5% | +$365K | 0.04% | 331 |
|
|
2021
Q1 | $6.2M | Buy |
40,548
+3,745
| +10% | +$573K | 0.04% | 362 |
|
|
2020
Q4 | $5.75M | Buy |
36,803
+5,253
| +17% | +$821K | 0.03% | 351 |
|
|
2020
Q3 | $3.61M | Sell |
31,550
-54
| -0.2% | -$6.18K | 0.02% | 411 |
|
|
2020
Q2 | $3.55M | Buy |
31,604
+184
| +0.6% | +$20.7K | 0.02% | 400 |
|
|
2020
Q1 | $2.82M | Buy |
31,420
+1,930
| +7% | +$173K | 0.02% | 402 |
|
|
2019
Q4 | $3.19M | Buy |
29,490
+672
| +2% | +$72.6K | 0.02% | 445 |
|
|
2019
Q3 | $2.82M | Buy |
28,818
+2,556
| +10% | +$250K | 0.02% | 416 |
|
|
2019
Q2 | $3.44M | Buy |
26,262
+922
| +4% | +$121K | 0.03% | 388 |
|
|
2019
Q1 | $3.43M | Buy |
25,340
+20,577
| +432% | +$2.78M | 0.03% | 401 |
|
|
2018
Q4 | $464K | Buy |
+4,763
| New | +$464K | ﹤0.01% | 631 |
|
|
2018
Q1 | – | Sell |
-1,279
| Closed | -$153K | – | 665 |
|
|
2017
Q4 | $153K | Sell |
1,279
-876
| -41% | -$105K | ﹤0.01% | 608 |
|
|
2017
Q3 | $302K | Sell |
2,155
-19,517
| -90% | -$2.74M | ﹤0.01% | 649 |
|
|
2017
Q2 | $2.64M | Sell |
21,672
-380
| -2% | -$46.2K | 0.02% | 326 |
|
|
2017
Q1 | $2.67M | Sell |
22,052
-3,147
| -12% | -$382K | 0.03% | 310 |
|
|
2016
Q4 | $3.08M | Sell |
25,199
-8,651
| -26% | -$1.06M | 0.03% | 296 |
|
|
2016
Q3 | $4.15M | Buy |
33,850
+3,000
| +10% | +$368K | 0.04% | 259 |
|
|
2016
Q2 | $3.6M | Sell |
30,850
-38,714
| -56% | -$4.52M | 0.03% | 267 |
|
|
2016
Q1 | $9.69M | Buy |
+69,564
| New | +$9.69M | 0.09% | 176 |
|